• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Spirometric Classifications of Chronic Obstructive Pulmonary Disease Severity as Predictive Markers for Clinical Outcomes: The HUNT Study.

作者信息

Bhatta Laxmi, Leivseth Linda, Mai Xiao-Mei, Henriksen Anne Hildur, Carslake David, Chen Yue, Martinez-Camblor Pablo, Langhammer Arnulf, Brumpton Ben Michael

机构信息

Norwegian University of Science and Technology Trondheim, Norway.

Northern Norway Regional Health Authority Tromsø, Norway.

出版信息

Am J Respir Crit Care Med. 2021 Apr 15;203(8):1033-1037. doi: 10.1164/rccm.202011-4174LE.

DOI:10.1164/rccm.202011-4174LE
PMID:33332249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8048755/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1250/8048755/e80155148ddb/rccm.202011-4174LEf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1250/8048755/4d86e590f00a/rccm.202011-4174LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1250/8048755/e80155148ddb/rccm.202011-4174LEf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1250/8048755/4d86e590f00a/rccm.202011-4174LEf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1250/8048755/e80155148ddb/rccm.202011-4174LEf2.jpg

相似文献

1
Spirometric Classifications of Chronic Obstructive Pulmonary Disease Severity as Predictive Markers for Clinical Outcomes: The HUNT Study.慢性阻塞性肺疾病严重程度的肺量计分类作为临床结局的预测指标：HUNT研究
Am J Respir Crit Care Med. 2021 Apr 15;203(8):1033-1037. doi: 10.1164/rccm.202011-4174LE.
2
GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway.GOLD 分类与慢性阻塞性肺疾病死亡率：挪威亨于普研究。
Thorax. 2013 Oct;68(10):914-21. doi: 10.1136/thoraxjnl-2013-203270. Epub 2013 Apr 23.
3
Comparison of stability of the GOLD and STAR lung function classification for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的GOLD和STAR肺功能分类稳定性比较。
BMJ Open Respir Res. 2025 May 16;12(1):e002830. doi: 10.1136/bmjresp-2024-002830.
4
Effects of one-hour training course and spirometry on the ability of physicians to diagnose and treat chronic obstructive pulmonary disease.一小时培训课程和肺活量测定法对医生诊断和治疗慢性阻塞性肺疾病能力的影响。
PLoS One. 2015 Feb 23;10(2):e0117348. doi: 10.1371/journal.pone.0117348. eCollection 2015.
5
Use of clinical characteristics to predict spirometric classification of obstructive lung disease.利用临床特征预测阻塞性肺疾病的肺量计分类
Int J Chron Obstruct Pulmon Dis. 2018 Mar 12;13:889-902. doi: 10.2147/COPD.S153426. eCollection 2018.
6
Spirometric Criteria for Chronic Obstructive Pulmonary Disease in Clinical Trials of Pharmacotherapy.药物治疗临床试验中慢性阻塞性肺疾病的肺量计标准
COPD. 2018 Feb;15(1):17-20. doi: 10.1080/15412555.2018.1424815.
7
[Evaluation of spirometric and pulmonary haemodynamic parameters in patients with COPD].[慢性阻塞性肺疾病患者肺量计和肺血流动力学参数的评估]
Tuberk Toraks. 2004;52(2):159-63.
8
Severity of chronic obstructive pulmonary disease with 'exacerbator with emphysema phenotype' is associated with potential biomarkers.具有“肺气肿表型加重者”特征的慢性阻塞性肺疾病严重程度与潜在生物标志物相关。
Postgrad Med J. 2020 Jan;96(1131):28-32. doi: 10.1136/postgradmedj-2019-136599. Epub 2019 Aug 2.
9
The objective evaluation of obstructive pulmonary diseases with spirometry.通过肺量计对阻塞性肺疾病进行客观评估。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 25;11:2009-15. doi: 10.2147/COPD.S113774. eCollection 2016.
10
Spirometric definition of COPD: exercise in futility or factual debate?慢性阻塞性肺疾病的肺量计定义：徒劳之举还是事实之争？
Thorax. 2012 Jul;67(7):569-70. doi: 10.1136/thoraxjnl-2012-201720. Epub 2012 Mar 30.

引用本文的文献

1
An updated comparison of standard and novel FEV1 indices' association with all-cause mortality.标准和新型第一秒用力呼气量（FEV1）指标与全因死亡率关联的最新比较
PLoS One. 2025 May 15;20(5):e0323681. doi: 10.1371/journal.pone.0323681. eCollection 2025.
2
Comparison of STAR and GOLD in Assessing Disease Severity Among High-Risk and COPD Patients: Evidence from Enjoying Breathing Program in China.STAR与GOLD在评估高危慢性阻塞性肺疾病（COPD）患者疾病严重程度中的比较：来自中国“畅享呼吸”项目的证据
Int J Chron Obstruct Pulmon Dis. 2024 Dec 27;19:2751-2762. doi: 10.2147/COPD.S492178. eCollection 2024.
3
Forced Expiratory Volume in One Second Quotient (FEV1Q) as a Prognostic Factor in Amyotrophic Lateral Sclerosis Patients: Comparing Its Predictive Value to Other Lung Function Measurements.

本文引用的文献

1
A Tutorial on Evaluating the Time-Varying Discrimination Accuracy of Survival Models Used in Dynamic Decision Making.用于动态决策的生存模型的时变判别精度评估教程。
Med Decis Making. 2018 Nov;38(8):904-916. doi: 10.1177/0272989X18801312. Epub 2018 Oct 14.
2
Prevalence and trend of COPD from 1995-1997 to 2006-2008: The HUNT study, Norway.1995-1997 年至 2006-2008 年期间 COPD 的患病率和趋势：挪威 HUNT 研究。
Respir Med. 2018 May;138:50-56. doi: 10.1016/j.rmed.2018.03.020. Epub 2018 Mar 21.
3
Comparison of different staging methods for COPD in predicting outcomes.
一秒用力呼气容积商（FEV1Q）作为肌萎缩侧索硬化症患者的预后因素：将其预测价值与其他肺功能测量指标进行比较。
Cureus. 2024 Feb 14;16(2):e54176. doi: 10.7759/cureus.54176. eCollection 2024 Feb.
4
FEVQ: a race-neutral approach to assessing lung function.FEVQ：一种评估肺功能的种族中立方法。
Eur Respir J. 2024 Apr 4;63(4). doi: 10.1183/13993003.01622-2023. Print 2024 Apr.
5
Can spirometry improve the performance of cardiovascular risk model in high-risk Eastern European countries?在东欧高危国家，肺功能测定能否改善心血管风险模型的性能？
Front Cardiovasc Med. 2023 Aug 29;10:1228807. doi: 10.3389/fcvm.2023.1228807. eCollection 2023.
6
FEV/FVC Severity Stages for Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病的 FEV/FVC 严重程度分期。
Am J Respir Crit Care Med. 2023 Sep 15;208(6):676-684. doi: 10.1164/rccm.202303-0450OC.
7
Decreased Cardiac Autonomic Function is Associated with Higher Exacerbation Risk and Symptom Burden in Chronic Obstructive Pulmonary Disease.心脏自主神经功能减退与慢性阻塞性肺疾病的更高急性加重风险和症状负担相关。
Chronic Obstr Pulm Dis. 2023 Jul 26;10(3):328-334. doi: 10.15326/jcopdf.2023.0410.
8
All-cause and cardiovascular mortality in relation to lung function in the full range of distribution across four Eastern European cohorts.在四个东欧队列中，在整个分布范围内，与肺功能相关的全因和心血管死亡率。
Sci Rep. 2022 Jul 28;12(1):12959. doi: 10.1038/s41598-022-17261-5.
比较不同分期方法在预测 COPD 结局中的作用。
Eur Respir J. 2018 Mar 15;51(3). doi: 10.1183/13993003.00577-2017. Print 2018 Mar.
4
Smooth time-dependent receiver operating characteristic curve estimators.平滑的时间依赖型接收器操作特性曲线估计器。
Stat Methods Med Res. 2018 Mar;27(3):651-674. doi: 10.1177/0962280217740786. Epub 2017 Nov 29.
5
Time-dependent ROC curve analysis in medical research: current methods and applications.医学研究中的时间依赖性ROC曲线分析：当前方法与应用
BMC Med Res Methodol. 2017 Apr 7;17(1):53. doi: 10.1186/s12874-017-0332-6.
6
Classification of Airflow Limitation Based on z-Score Underestimates Mortality in Patients with Chronic Obstructive Pulmonary Disease.基于 z 评分的气流受限分类低估了慢性阻塞性肺疾病患者的死亡率。
Am J Respir Crit Care Med. 2017 Aug 1;196(3):298-305. doi: 10.1164/rccm.201611-2265OC.
7
Global Lung Function Initiative 2012 reference equations for spirometry in the Norwegian population.全球肺功能倡议 2012 年挪威人群肺量测定法参考方程。
Eur Respir J. 2016 Dec;48(6):1602-1611. doi: 10.1183/13993003.00443-2016. Epub 2016 Oct 6.
8
Use of forced vital capacity and forced expiratory volume in 1 second quality criteria for determining a valid test.使用用力肺活量和1秒用力呼气量质量标准来确定有效测试。
Eur Respir J. 2015 May;45(5):1283-92. doi: 10.1183/09031936.00116814. Epub 2014 Dec 23.
9
Grading the severity of airways obstruction: new wine in new bottles.气道阻塞严重程度分级：旧瓶新酒。
Eur Respir J. 2014 Feb;43(2):505-12. doi: 10.1183/09031936.00086313. Epub 2013 Aug 29.
10
Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.用于 3-95 岁年龄范围的肺量测定的多民族参考值：全球肺功能 2012 方程。
Eur Respir J. 2012 Dec;40(6):1324-43. doi: 10.1183/09031936.00080312. Epub 2012 Jun 27.